Use op brivaracetam for the treatment of diseases characterized by progressive myoclonic epilepsy

Details for Australian Patent Application No. 2006256954 (hide)

Owner UCB Pharma, S.A.

Inventors Verdru, Peter

Agent Watermark

Pub. Number AU-A-2006256954

PCT Pub. Number WO2006/131322

Priority 05012270.4 08.06.05 EP

Filing date 7 June 2006

Wipo publication date 14 December 2006

International Classifications

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131322 Priority application(s): WO2006/131322

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256962-Network controlled classification of service tariff class

2006256947-Apparatus and method for paint coating or varnish coating a coilable metal sheet